Cara Therapeutics | CARA - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Acadia Pharmaceuticals USD 272.68M 6.08M 2026-03
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Cassava Sciences USD 11.17M 2.38M 2026-03
Chugai Pharma JPY 162.98B 14.31B 2026-03
Cipla INR 59.27B 1.71B 2026-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 192.19M 18.88M 2026-03
J&J USD 17.44B 1.53B 2026-03
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Pacira USD 172.75M 20.93M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
RedHill Biopharma USD 5.51M 1.08M 2024-06
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12